Keywords: Conducting polymers; PEDOT-Based materials; Nanomaterials; Electrochemical sensors; 1-m-4-MP; 1-methyl-4-mercaptopyridine; AAT; acetic acid thiophene; AChE-ChO; acetylcholinesterase-choline oxidase; AlcDH; alcohol oxidase; AMP; amperometric; AO; ascorbate
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CK; Creatine kinase; DBS; Dried blood spot; GAA; Alpha-glucosidase; GAG; Glycosaminoglycan; GBA; Beta-glucosidase; IDUA; Alpha-L-iduronidase; IOPD; Infantile-onset Pompe disease; LOPD; Late-onset Pompe disease; LSD; Lysosomal storage disorder; MPS; Mucopo
Keywords: MPS; mucopolysaccharidosis; GAG; glycosaminoglycang; CS; chondroitin sulfate; DS; dermatan sulfate; HS; heparan sulfate; KS; keratan sulfate; ECM; extracellular matrix; IDUA; α-l-iduronidase; I2S; iduronate-2-sulfatse; SGHS; heparan-N-sulfatase; NAGLU; Î
Keywords: Mucopolysaccharidosis (MPS); Lysosomal storage disease (LSD); IDUA; IDS; SGSH; NAGLU; GALNS; Whole Exome Sequencing (WES); Mutation;
Keywords: AFM; atomic force microscopy; APC; antigen-presenting cell; CNE; cationic nanoemulsion; COL; cholesterol; CTAB; cetyltrimethylammonium bromide; DC-Chol; 3-b[N-(N0,N0-dimethylaminoethane)-carbamoyl] cholesterol; DDA; dimethyldioctadecylammonium (bromide sa
Keywords: LSD; lysosomal storage disease; CNS; central nervous system; BBB; blood-brain barrier; ERT; enzyme replacement therapy; GAG; glycosaminoglycans; CSF; cerebrospinal fluid; FDA; food and drug administration; ICV; intracerebroventricular; HLA; human leukocyt
Keywords: DBS; Dried blood spot; GAA; Acid α-glucosidase; GBA; Acid β-d-glucosidase; GLA; Acid α-galactosidase; IDUA; Acid α-l-iduronidase; LSD; Lysosomal storage disorder; MPS I; Mucopolysaccharidosis type I; MSPHL; Missouri State Public Health Laboratory; NBS
Keywords: DBS; Dried blood spots collected on filter paper; MPS I; Mucopolysaccharidosis type I; MPS VI; Mucopolysaccharosis type VI; LSDs; Lysosomal storage disorders; LC/MS/MS; Liquid chromatography combined with tandem mass spectrometry; GAL; Alpha-galactosidase
Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management
Keywords: CNS; Central nervous system; DBS; Dried blood spot; ERT; Enzyme replacement therapy; GAG; Glycosaminoglycan; HSCT; Hematopoietic stem cell transplantation; IDUA; α-L-iduronidase; MPS; Mucopolysaccharidoses; MPS I; Mucopolysaccharidosis type I; MRI; Magne
Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry
Keywords: DBS; Dried blood spot on a newborn screening card; GAA; Acid α-glucosidase; GALC; Galactocerebrosidase; GBA; Glucocerebrosidase; GLA; α-Galactosidase A; IDUA; α-Iduronidase; MPS-I; Mucopolysaccharidosis-I; MS/MS; Tandem mass spectrometry; MRM; Multiple
Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I
Keywords: OSAS; obstructive sleep apnea syndrome; MPS I; mucopolysaccharidosis I; HSCT; hematopoietic stem cell transplantation; PSG; polysomnography; AHI; apnea-hypopnea index; GAG; glycosaminoglycan; IDUA; a-L-iduronidase; MPS I-H; Hurler syndrome; MPS I-S; Sch
Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of L-iduronidase from dried blood spots
Keywords: MPS I; mucopolysaccharidosis I; IDUA; L-iduronidase; LSD; lysosomal storage diseases; DBS; dried blood spots; 4-MU-ID; 4-methylumbelliferyl-α-L-iduronide; TCA; trichloroacetic acid; 4-MU; 4-methylumbelliferone; Lysosomal storage diseases; MPS I; IDUA; Dr
Residual α-l-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients
Keywords: 4MU; 4-methylumbelliferone; ERT; enzyme-replacement therapy; HSCT; hematopoietic stem cell transplantation; IDUA; α-l-iduronidase; MPS; mucopolysaccharidosis; MPS IH; Hurler syndrome; MPS IH/S; Hurler-Scheie syndrome; MPS IS; Scheie syndrome; Mucopolys
Original ArticleIdentification of Infants at Risk for Developing Fabry, Pompe, or Mucopolysaccharidosis-I from Newborn Blood Spots by Tandem Mass Spectrometry
Keywords: CDC; Centers for Disease Control and Prevention; GAA; α-glucosidase; GLA; α-galactosidase; IDUA; α-L-iduronidase; LSD; Lysosomal storage disease; MPS; Mucopolysaccharidosis; MS/MS; Tandem mass spectrometry; PCR; Polymerase chain reaction; QC; Quality c
Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs
Keywords: MPS; Mucopolysaccharidosis; GAG; Glycosaminoglycan; MV; mitral valve; MR; mitral regurgitation; GUSB; β-glucuronidase; OMIM; Online Mendelian Inheritance in Man; HSCT; hematopoietic stem cell transplantation; ERT; enzyme replacement therapy; IV; Intraven
Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury
Keywords: BSM; bovine submaxillary gland mucus; CS; chondroitin sulfate; DAMP; damage-associated molecular pattern; DAPI; 4â²,6-diamidino-2-phenylindole; DC; dendritic cell; ecSOD; extracellular superoxide dismutase; eNOS; endothelial nitric oxide synthase; ET-1;
A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants
Keywords: Cq; quantification cycles; DS; dermatan sulfate; ERT; enzyme replacement therapy; GAGs; glycosaminoglycans; HSCT; hematopoietic stem cell transplantation; HS; heparan sulfate; IDUA; α-l-iduronidase; MPS I; mucopolysaccharidosis type I; PTC; premature ter
Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation
Keywords: MPS; mucopolysaccharidosis; Cts; cathepsin; MMP; matrix metalloproteinase; GUSB; β-glucuronidase; GAGs; glycosaminoglycans; TLR4; toll-like receptor 4; TNFα; tumor necrosis factor alpha; IL-6; interleukin 6; M6P; mannose 6-phosphate; ERT; enzyme replace
Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of α-l-iduronidase mutations causing mucopolysaccharidosis type I
Keywords: Mucopolysaccharidosis type I; MPS I; α-l-Iduronidase; IDUA; dHPLC
Guidelines for the Management of Mucopolysaccharidosis Type I
Keywords: ADLs; Activities of daily living; ATR; Abdominal thorax rebalance; BAEP; Brain stem auditory evoked potential; BHM; Bronchial hygiene maneuvers; BMT; Bone marrow transplant; CFP; Federal Psychology Council; CH; Communicating hydrocephalus; CHF; Congestive
Haplotypes Eco47 III-Nsp I sites frequencies on the IDUA gene in Mexican native population
Keywords: IDUA; Eco47 III; Nsp I; Mexican population; Gene frequencies;